Home / Tag: Ornithine Transcarbamylase (OTC) Deficiency

Tag Archives: Ornithine Transcarbamylase (OTC) Deficiency

Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-810

Treatment of Ornithine Transcarbamylase (OTC) Deficiency San Diego CA—Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a leading RNA medicines company focused on the development and commercialization of therapeutics towards ...

Read More »

Arcturus Therapeutics to Develop ARCT-810 for Treatment of Ornithine Transcarbamylase (OTC) Deficiency

San Diego CA—  Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company focused on the development and commercialization of therapeutics towards rare,  liver and respiratory diseases with ...

Read More »